Holen Sie sich die Stockscreener-App
8.785
0.29%
0.045
Schlusskurs vom Vortag:
$8.74
Offen:
$8.74
24-Stunden-Volumen:
3.59M
Relative Volume:
0.50
Marktkapitalisierung:
$1.55B
Einnahmen:
$2.54B
Nettoeinkommen (Verlust:
$-207.36M
KGV:
-7.3824
EPS:
-1.19
Netto-Cashflow:
$151.25M
1W Leistung:
-7.35%
1M Leistung:
+13.39%
6M Leistung:
+21.91%
1J Leistung:
-2.61%
1-Tages-Spanne:
$8.61
$9.15
1-Wochen-Bereich:
$7.96
$9.77
52-Wochen-Spanne:
$6.35
$15.21
Teladoc Health Inc Stock (TDOC) Company Profile
Firmenname
Teladoc Health Inc
Sektor
Branche
Telefon
(203) 635-2002
Adresse
155 E 44TH STREET, NEW YORK, NY
Vergleichen Sie TDOC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TDOC
Teladoc Health Inc
|
8.795 | 1.55B | 2.54B | -207.36M | 151.25M | -1.19 |
|
VEEV
Veeva Systems Inc
|
289.75 | 46.72B | 2.97B | 809.93M | 1.33B | 4.8743 |
|
TEM
Tempus Ai Inc
|
89.27 | 14.99B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
66.64 | 12.33B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
94.70 | 8.01B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
37.27 | 7.09B | 906.14M | -52.62M | 89.62M | -0.3621 |
Teladoc Health Inc Stock (TDOC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-25 | Eingeleitet | Mizuho | Neutral |
| 2024-11-15 | Eingeleitet | Goldman | Buy |
| 2024-09-17 | Bestätigt | Jefferies | Hold |
| 2024-02-29 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-02-26 | Eingeleitet | Leerink Partners | Market Perform |
| 2024-01-17 | Herabstufung | DA Davidson | Buy → Neutral |
| 2024-01-03 | Eingeleitet | Barclays | Overweight |
| 2023-04-12 | Eingeleitet | Stephens | Equal-Weight |
| 2023-02-23 | Hochstufung | SVB Securities | Market Perform → Outperform |
| 2022-10-24 | Hochstufung | Guggenheim | Sell → Neutral |
| 2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2022-09-07 | Eingeleitet | Truist | Hold |
| 2022-08-17 | Herabstufung | Guggenheim | Neutral → Sell |
| 2022-08-12 | Eingeleitet | DA Davidson | Buy |
| 2022-08-02 | Herabstufung | Berenberg | Buy → Hold |
| 2022-08-02 | Herabstufung | Cowen | Outperform → Market Perform |
| 2022-07-28 | Herabstufung | Goldman | Buy → Neutral |
| 2022-07-28 | Herabstufung | Needham | Buy → Hold |
| 2022-07-06 | Bestätigt | BofA Securities | Neutral |
| 2022-05-05 | Herabstufung | Argus | Buy → Hold |
| 2022-04-28 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-04-28 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2022-04-28 | Herabstufung | Guggenheim | Buy → Neutral |
| 2022-04-28 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-04-28 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2022-04-28 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-04-28 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2022-04-07 | Eingeleitet | Guggenheim | Buy |
| 2022-04-01 | Fortgesetzt | Credit Suisse | Outperform |
| 2022-03-03 | Hochstufung | Argus | Hold → Buy |
| 2022-02-23 | Bestätigt | BofA Securities | Neutral |
| 2022-02-23 | Bestätigt | Craig Hallum | Hold |
| 2022-02-23 | Bestätigt | Evercore ISI | In-line |
| 2022-02-23 | Bestätigt | Goldman | Buy |
| 2022-02-23 | Bestätigt | JP Morgan | Overweight |
| 2022-02-23 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2022-02-23 | Bestätigt | Needham | Buy |
| 2022-02-23 | Bestätigt | Oppenheimer | Outperform |
| 2022-02-23 | Bestätigt | Stifel | Hold |
| 2022-02-11 | Eingeleitet | Goldman | Buy |
| 2022-02-08 | Bestätigt | Piper Sandler | Overweight |
| 2021-12-02 | Fortgesetzt | Jefferies | Hold |
| 2021-11-22 | Herabstufung | BTIG Research | Buy → Neutral |
| 2021-10-28 | Bestätigt | Barclays | Equal Weight |
| 2021-10-28 | Bestätigt | BofA Securities | Neutral |
| 2021-10-28 | Bestätigt | Canaccord Genuity | Buy |
| 2021-10-28 | Bestätigt | Citigroup | Buy |
| 2021-10-28 | Bestätigt | Craig Hallum | Hold |
| 2021-10-28 | Bestätigt | Needham | Buy |
| 2021-10-28 | Bestätigt | Oppenheimer | Outperform |
| 2021-10-28 | Bestätigt | Piper Sandler | Overweight |
| 2021-10-28 | Bestätigt | UBS | Neutral |
| 2021-10-19 | Eingeleitet | Wells Fargo | Overweight |
| 2021-08-02 | Herabstufung | Argus | Buy → Hold |
| 2021-07-28 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2021-05-28 | Eingeleitet | Robert W. Baird | Neutral |
| 2021-04-15 | Eingeleitet | Needham | Buy |
| 2021-01-07 | Eingeleitet | BTIG Research | Buy |
| 2020-12-22 | Eingeleitet | Evercore ISI | In-line |
| 2020-12-07 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2020-12-04 | Eingeleitet | Goldman | Neutral |
| 2020-11-13 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2020-09-22 | Eingeleitet | DA Davidson | Buy |
| 2020-09-02 | Hochstufung | Berenberg | Hold → Buy |
| 2020-08-17 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2020-07-14 | Eingeleitet | Citigroup | Buy |
| 2020-07-13 | Eingeleitet | Argus | Buy |
| 2020-07-07 | Eingeleitet | Stephens | Overweight |
| 2020-04-30 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2020-04-13 | Eingeleitet | SVB Leerink | Outperform |
| 2020-03-31 | Herabstufung | Berenberg | Buy → Hold |
| 2020-03-25 | Herabstufung | Craig Hallum | Buy → Hold |
| 2020-03-16 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-03-12 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2020-02-28 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-02-12 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2020-01-10 | Eingeleitet | UBS | Neutral |
| 2020-01-09 | Herabstufung | BofA/Merrill | Buy → Neutral |
Alle ansehen
Teladoc Health Inc Aktie (TDOC) Neueste Nachrichten
Teladoc Health, Inc. (NYSE:TDOC) Q3 2025 Earnings Call Transcript - Insider Monkey
Will Teladoc Health Inc. (4LL) stock outperform small cap peers2025 Performance Recap & Real-Time Volume Analysis - newser.com
How Teladoc Health Inc. stock performs after earningsWeekly Trade Analysis & Risk Controlled Swing Alerts - newser.com
Can trapped investors hope for a rebound in Teladoc Health Inc.2025 Price Targets & Risk Controlled Daily Plans - newser.com
Will Teladoc Health Inc. (4LL) stock enhance shareholder valueMarket Weekly Review & Safe Capital Growth Tips - newser.com
How to recover losses in Teladoc Health Inc. stockWeekly Profit Report & Reliable Volume Spike Trade Alerts - newser.com
Can Teladoc Health Inc. (4LL) stock sustain revenue momentumRisk Management & Weekly High Return Stock Opportunities - newser.com
Is Teladoc Health Inc. stock a contrarian opportunity2025 Key Lessons & Technical Pattern Based Signals - newser.com
How Teladoc Health Inc. (4LL) stock behaves under inflation pressure2025 Price Momentum & Risk Controlled Daily Trade Plans - newser.com
Is Teladoc Health Inc. stock a buy before earnings resultsJuly 2025 Macro Moves & Reliable Volume Spike Trade Alerts - newser.com
Will Teladoc Health Inc. stock boost dividends furtherJuly 2025 Earnings & Real-Time Sentiment Analysis - newser.com
Will Teladoc Health Inc. stock return to pre crash levelsEarnings Risk Report & Safe Swing Trade Setup Alerts - newser.com
Order flow analysis tools used on Teladoc Health Inc.July 2025 Price Swings & Accurate Trade Setup Notifications - newser.com
Teladoc Health (NYSE:TDOC) Issues Q4 2025 Earnings Guidance - MarketBeat
Teladoc Health’s Earnings Call: Resilience Amid Challenges - TipRanks
Teladoc Finds Its Groove With Strong Q3, AI Push - TradingView
Teladoc Health (NYSE:TDOC) Releases Earnings Results, Beats Estimates By $0.05 EPS - MarketBeat
Teladoc Health Inc (TDOC) Q3 2025 Earnings Call Highlights: Navigating Challenges and Seizing ... By GuruFocus - Investing.com Canada
Teladoc Health (TDOC): Evercore ISI Group Adjusts Price Target | TDOC Stock News - GuruFocus
Teladoc Health Inc (TDOC) Q3 2025 Earnings Call Highlights: Navigating Challenges and Seizing ... - Yahoo Finance
Teladoc expands insurance coverage at mental health unit BetterHelp - Healthcare Dive
Why Teladoc (TDOC) Stock Is Trading Up Today - MSN
Teladoc Health, Inc. SEC 10-Q Report - TradingView
When will things look better for Teladoc? - statnews.com
TDOC Q3 CY2025 Deep Dive: Insurance Pivot, International Growth, and Margin Pressures - TradingView
How to integrate Teladoc Health Inc. into portfolio analysis tools2025 Volatility Report & Low Drawdown Trading Techniques - newser.com
How Teladoc Health Inc. stock valuations compare to rivalsWatch List & Reliable Price Breakout Alerts - newser.com
Trend analysis for Teladoc Health Inc. this week2025 Technical Overview & Technical Pattern Alert System - newser.com
Should you wait for a breakout in Teladoc Health Inc.2025 Geopolitical Influence & High Accuracy Investment Signals - newser.com
58,450 Shares in Teladoc Health, Inc. $TDOC Bought by Wealth Management Associates Inc. - MarketBeat
Digital Therapeutics and Virtual Care Suite Market Future - openPR.com
How Teladoc Health Inc. (4LL) stock compares with top peersPortfolio Value Summary & Intraday High Probability Setup Alerts - newser.com
Will a bounce in Teladoc Health Inc. offer an exitForecast Cut & High Win Rate Trade Alerts - newser.com
Teladoc Health Reports Q3 2025 Financial Results - TipRanks
Teladoc Health (TDOC) Reports Strong Q3 Performance and Strategi - GuruFocus
Why Teladoc Health Inc. stock could be next big winnerBond Market & AI Powered Market Trend Analysis - newser.com
Teladoc Inc earnings missed by $0.02, revenue topped estimates - Investing.com
Teladoc (TDOC) Q3 2025 Earnings Call Transcript - The Globe and Mail
Teladoc’s Revenue Tops Forecasts Even As Losses Deepen - Finimize
Teladoc (TDOC) Reports Q3 Earnings: What Key Metrics Have to Say - Yahoo! Finance Canada
Teladoc Health Reports Third Quarter 2025 Results - MarketScreener
Teladoc Health (TDOC) Faces Challenges Despite Revenue Consisten - GuruFocus
Teladoc (TDOC) Reports Q3 Loss, Beats Revenue Estimates - Yahoo Finance
Teladoc (TDOC) Reports Q3 Revenue Slightly Below Expectations - GuruFocus
Teladoc (TDOC) Announces Projected Q4 Revenue, Expects Strong Pe - GuruFocus
Teladoc Health Posts Mixed Results For Q3, Shares Move LowerTeladoc Health (NYSE:TDOC) - Benzinga
Teladoc (TDOC) Projects FY25 Revenue to Align with Market Expectations - GuruFocus
Teladoc Health, Inc. (TDOC) Q3 FY2025 earnings call transcript - Yahoo Finance
Teladoc’s (NYSE:TDOC) Q3 Earnings Results: Revenue In Line With Expectations - The Globe and Mail
Teladoc Health Inc Stock Analysis and ForecastLong-Term Investment Plans & Create Passive Income With Smart Stocks - earlytimes.in
United States Digital Therapeutics Market 2025: Industry - openPR.com
Finanzdaten der Teladoc Health Inc-Aktie (TDOC)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.41%
0.02%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):